nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2024, 03, v.43 522-533
基于网络药理学探究芍药苷治疗糖尿病视网膜病变的机制
基金项目(Foundation): 国家自然科学基金面上项目(81874384); 浦东新区卫建委联合攻关项目(PW2021D-03)共同资助
邮箱(Email): zouhong2007@126.com;
DOI: 10.13417/j.gab.043.000522
发布时间: 2023-10-17
出版时间: 2023-10-17
网络发布时间: 2023-10-17
移动端阅读
摘要:

本研究通过体外实验与网络药理学相结合的方法分析芍药苷治疗糖尿病视网膜病变的相关作用机制。制备高糖环境下视网膜血管内皮细胞的体外模型,探究芍药苷对糖尿病视网膜病变的保护作用;从TCMSP、 UniProt、 PubChem、 PharmMapper、 SwisstargetPrediction、 GeneCards、 OMIM、 DrugBank、 TTD数据库获取芍药苷和糖尿病视网膜病变的作用靶点,使用韦恩图获取核心靶点;基于STRING数据库,采用Cytoscape构建蛋白质-蛋白质相互作用网络和“药物-靶点-疾病”网络;应用DAVID数据库对核心靶点进行GO功能富集分析和KEGG通路富集分析,并用AutoDock软件将芍药苷与核心靶点进行分子对接验证。体外实验结果显示,芍药苷能显著抑制视网膜血管内皮细胞的增殖,降低其迁移能力并减少管腔形成长度。网络药理学结果显示共获取芍药苷治疗糖尿病视网膜病变的核心靶点154个,其中度值较高的靶点包括VEGFA、 IL6等。GO功能共富集到705个GO条目,主要涉及细胞对药物的反应、血管内皮细胞迁移的调节、细胞增殖的调节等生物过程;KEGG通路富集分析共富集到137条通路,主要包括AGE-RAGE信号通路和PI3K-Akt信号通路。分子对接结果显示,芍药苷分子与核心靶点VEGFA、 IL6的结合能力良好。本研究表明芍药苷可能通过多靶点、多通路调节视网膜血管内皮细胞的增殖、迁移能力及管腔形成长度等发挥治疗糖尿病视网膜病变的作用。

Abstract:

In this study, the combination of in vitro experiments and network pharmacology was used to explore the mechanism of paeoniflorin in treating diabetic retinopathy. An in vitro model of retinal vascular endothelial cells under high glucose environment was prepared to explore the protective effect of paeoniflorin on diabetic retinopathy. The targets of paeoniflorin and diabetic retinopathy were obtained from TCMSP, UniProt, PubChem, PharmMapper, SwisstargetPrediction, GeneCards, OMIM, DrugBank, TTD databases, and the core targets were obtained by Venn diagram. Based on the STRING database, the protein-protein interaction network and a “drug-target-disease” network were constructed using Cytoscape; The DAVID database was used to carry out GO biological process and KEGG pathway enrichment to analyze the core target, and the AutoDock software was used to carry out molecular docking verification between paeoniflorin and the core target. In vitro experimental results show that paeoniflorin can significantly inhibit the proliferation and migration ability of retinal vascular endothelial cells and reduce the length of lumen formation. The results of network pharmacology show that a total of 154 core targets for the treatment of diabetic retinopathy with paeoniflorin have been obtained, among which higher degree targets include VEGFA, IL6, etc. The GO function is enriched to 705 GO items, mainly involving cell response to drugs, the regulation of vascular endothelial cell migration, regulation of cell proliferation and other biological processes; The KEGG pathway enrichment analysis enriched a total of 137 pathways, mainly including the AGE-RAGE signaling pathway and the PI3K-Akt signaling pathway. Molecular docking results showed that paeoniflorin molecules had good binding ability to core targets VEGFA and IL6. This study suggests that paeoniflorin may play a role in the treatment of diabetic retinopathy by regulating the proliferation, migration ability and lumen formation length of retinal vascular endothelial cells through multiple targets and pathways.

参考文献

冯晓彤,柯静,朱琳,等,2023.糖尿病视网膜病变的病理生理学研究进展.首都医科大学学报,44(3):420-423.[FENG X T,KE J,ZHU L,et al.,2023.Progress in the pathophysiology of diabetic retinopathy.Journal of Capital Medical University,44(3):420-423.]

黄富文,吴文钦,何银英,等,2022.芍药苷对糖尿病大血管病变模型小鼠的干预作用.岭南急诊医学杂志,27(2):105-107,111.[HUANG F W,WU W Q,HE Y Y,et al.,2022.Effect of paeoniflorin on diabetic macroangiopathy mice.Lingnan Journal of Emergency Medicine,27(2):105-107,111.]

毛羽佳,殷俏,郑琳璐,等,2022,松果菊苷对高糖诱导的人视网膜毛细血管内皮细胞增殖、 迁移及新生血管形成的影响.眼科新进展,42(4):272-277.[MAO Y J,YIN Q,ZHENG L L,et al.,2022.Effect of echinacoside on proliferation,migration and angiogenesis of humanretinal capillary endothelial cells induced by high glucose.Recent Advances in Ophthalmology,42(4):272-277.]

桑智慧,李慧红,周丽娟,2023.中药治疗糖尿病视网膜病变的疗效及机制研究进展.中国药房,34(12):1532-1536.[SANG Z H,LI H H,ZHOU L J,2023.Research progress on the efficacy and mechanism of traditional Chinese medicine in the treatment of diabetic retinopathy.China Pharmacy,34(12):1532-1536.]

徐芳,李红红,刘念,等,2019.糖尿病视网膜病变患者疾病感知现状及影响因素分析.皖南医学院学报,38(4):379-382.[XU F,LI H H,LIU N,et al.,2019.Analysis on the status of disease perception and influencing factors in patients with diabetic retinopathy.Journal of Wannan Medical College,38(4):379-382.]

张博,李凤君,刘学政,等,2023.芍药苷基于JAK2/STAT3信号通路抑制糖尿病大鼠视网膜细胞炎症的研究.中国中医眼科杂志,33(4):305-310.[ZHANG B,LI F J,LIU X Z,et al.,2023.Paeoniflorin inhibit retinal cell inflammation in diabetic rats based on the JAK2/STAT3 signaling pathway.China Journal of Chinese Ophthalmology,33(4):305-310.]

张建军,李伟,乐娜,等,2020.赤芍及赤芍总单萜、 赤芍总酚对热毒血瘀证大鼠的清热凉血散瘀功效.北京中医药大学学报,43(3):196-202.[ZHANG J J,LI W,YUE N,et al.,2020.Effects of Chishao,its total monoterpenes and its total phenols on clearing heat,cooling blood and dissolving stasis in rats with heat toxicity and blood stasis pattern.Journal of Beijing University of Traditional Chinese Medicine,43(3):196-202.]

宗阳,丁美林,贾可可,等,2020.基于网络药理学和分子对接法探寻达原饮治疗新型冠状病毒肺炎(COVID-19)活性化合物的研究.中草药,51(4):836-844.[ZONG Y,DING M L,JIA K K,et al.,2020.Exploring active compounds of Da-Yuan-Yin in treatment of COVID-19 based on network pharmacology and molecular docking method.Chinese Traditional and Herbal Drugs,51(4):836-844.]

AMBERGER J S,HAMOSH A,2017.Searching online Mendelian inheritance in man (OMIM):a knowledgebase of human genes and genetic phenotypes.Curr.Protoc.Bioinformatics,58:1.2.1-1.2.12.

BELI E,YAN Y Q,MOLDOVAN L,et al.,2018.Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice.Diabetes,67(9):1867-1879.

CHEN S,LIAO M M,LI J P,et al.,2020.The correlation between microvessel pathological changes of the endplate and degeneration of the intervertebral disc in diabetic rats.Exp.Ther.Med.,20(5):1.

DAINA A,MICHIELIN O,ZOETE V,2019.SwissTargetPrediction:updated data and new features for efficient prediction of protein targets of small molecules.Nucleic Acids Res.,47(W1):W357-W364.

DONCHEVA N T,MORRIS J H,GORODKIN J,et al.,2019.Cytoscape stringApp:network analysis and visualization of proteomics data.J.Proteome Res.,18(2):623-632.

FORRESTER J V,KUFFOVA L,DELIBEGOVIC M,2020.The role of inflammation in diabetic retinopathy.Front.Immunol.,11:583687.

GIURDANELLA G,LAZZARA F,CAPORARELLO N,et al.,2017.Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE.Biochem.Pharmacol.,142:145-154.

HEYDARI M,MICLOTTE G,DEMEESTER P,et al.,2017.Evaluation of the impact of Illumina error correction tools on de novo genome assembly.BMC Bioinformatics,18(1):374.

HUANG D W,SHERMAN B T,LEMPICKI R A,2009.Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.Nat.Protoc.,4(1):44-57.

KIM S,CHEN J,CHENG T J,et al.,2021.PubChem in 2021:new data content and improved web interfaces.Nucleic Acids Res.,49(D1):D1388-D1395.

KONG H,ZHAO H R,CHEN T R,et al.,2022.Targeted P2X7/NLRP3 signaling pathway against inflammation,apoptosis,and pyroptosis of retinal endothelial cells in diabetic retinopathy.Cell Death Dis.,13(4):336.

LU J M,ZHANG Z Z,MA X,et al.,2020.Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.Exp.Eye Res.,190:107886.

LUSSI Y C,MAGRANE M,MARTIN M J,et al.,2023.Searching and navigating UniProt databases.Curr.Protoc.,3(3):e700.

NOMA H,YASUDA K,SHIMURA M,2021.Involvement of cytokines in the pathogenesis of diabetic macular edema.Int.J.Mol.Sci.,22(7):3427.

RAPPAPORT N,TWIK M,PLASCHKES I,et al.,2017.MalaCards:an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search.Nucleic Acids Res.,45(D1):D877-D887.

SZKLARCZYK D,GABLE A L,NASTOU K C,et al.,2021.The STRING database in 2021:customizable protein-protein networks,and functional characterization of user-uploaded gene/measurement sets.Nucleic Acids Res.,49(D1):D605-D612.

TAN Y Q,CHEN H W,LI J,et al.,2020.Efficacy,chemical constituents,and pharmacological actions of Radix Paeoniae Rubra and Radix Paeoniae Alba.Front.Pharmacol.,11:1054.

WANG J S,HUANG Y,ZHANG S P,et al.,2019.A protective role of paeoniflorin in fluctuant hyperglycemia-induced vascular endothelial injuries through antioxidative and anti-inflammatory effects and reduction of PKCβ1.Oxid.Med.Cell.Longev.,2019:5647219.

WANG W,LO A C Y,2018.Diabetic retinopathy:pathophysiology and treatments.Int.J.Mol.Sci.,19(6):1816.

WANG X,SHEN Y H,WANG S W,et al.,2017.PharmMapper 2017 update:a web server for potential drug target identification with a comprehensive target pharmacophore database.Nucleic Acids Res.,45(W1):W356-W360.

WEN J,XU B,SUN Y C,et al.,2019.Paeoniflorin protects against intestinal ischemia/reperfusion by activating LKB1/AMPK and promoting autophagy.Pharmacol.Res.,146:104308.

WISHART D S,FEUNANG Y D,GUO A C,et al.,2018.DrugBank 5.0:a major update to the DrugBank database for 2018.Nucleic Acids Res.,46(D1):D1074-D1082.

XIANG Y J,ZHANG Q,WEI S J,et al.,2020.Paeoniflorin:a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities.J.Pharm.Pharmacol.,72(4):483-495.

YU G Y,WANG Z T,ZENG S L,et al.,2019.Paeoniflorin inhibits hepatocyte growth factor- (HGF-) induced migration and invasion and actin rearrangement via suppression of c-Met-mediated RhoA/ROCK signaling in glioblastoma.Biomed Res.Int.,2019:9053295.

ZHANG L L,HAN L,MA J,et al.,2022.Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology.Eur.J.Pharmacol.,919:174769.

ZHANG X,ZHU J L,YAN J N,et al.,2020.Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L.for non-small cell lung cancer.Phytomedicine,79:153326.

ZHOU Y,ZHANG Y T,LIAN X C,et al.,2022.Therapeutic target database update 2022:facilitating drug discovery with enriched comparative data of targeted agents.Nucleic Acids Res.,50(D1):D1398-D1407.

基本信息:

DOI:10.13417/j.gab.043.000522

中图分类号:R285

引用信息:

[1]李景景,凌芸,唐慧新,等.基于网络药理学探究芍药苷治疗糖尿病视网膜病变的机制[J].基因组学与应用生物学,2024,43(03):522-533.DOI:10.13417/j.gab.043.000522.

基金信息:

国家自然科学基金面上项目(81874384); 浦东新区卫建委联合攻关项目(PW2021D-03)共同资助

发布时间:

2023-10-17

出版时间:

2023-10-17

网络发布时间:

2023-10-17

检 索 高级检索